echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nat Commun: Giving two peptides through the nose is expected to slow the progression of Parkinson's disease

    Nat Commun: Giving two peptides through the nose is expected to slow the progression of Parkinson's disease

    • Last Update: 2021-10-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In a new study, researchers from the Rush University Medical Center in the United States have made new progress in the treatment of Parkinson’s disease: the potential new treatment for Parkinson’s disease they developed has shown to slow the progression of the disease in mice.


    Specifically, the authors found that two different peptides help slow the spread of alpha-synuclein, an abnormal protein deposit called Lewy body in the brain.


    Lewy bodies are also related to dementia with Lewy bodies and a rare neurological disease---multiple system atrophy (MSA)


    The activation of NF-κB increases the expression of α-synuclein in neurons


    The two peptides tested in this new study are called Myd88's TLR2 interaction domain (TLR2-interacting domain, TIDM) and NEMO-binding domain (NEMO-binding domain, NBD)


    Note: The original text has been deleted

    Reference materials:

    Debashis Dutta et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.